Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
87,15 USD | +0,26 % | +4,48 % | +5,79 % |
Kurzporträt
- Allgemeine und minimalinvasive Chirurgie (28,8%): chirurgische Geräte, intraoperative Überwachungssysteme, Beatmungssysteme usw.;
- Herzrhythmusmanagement (18,6%): implantierbare Herzschrittmacher, implantierbare Defibrillatoren und automatische externe Defibrillatoren, Herzablationssonden usw.;
- Gefäßerkrankungen und Herzchirurgie (17.4%): Koronarstents, Endoprothesen für Aortenpathologien, distale Schutzsysteme, Katheter, Herzklappenprothesen, Autotransfusionsgeräte, Herzablationsgeräte usw.;
- Wirbelsäulenerkrankungen (14,1%): Wirbelsäulenprothesen, Bandscheibenprothesen, Systeme zur zerebralen Stimulation, Knochentransplantationstechnologien und mini-invasive Wirbelsäulenchirurgie usw. Die Gruppe entwickelt auch medizinische bildgestützte chirurgische Navigationssysteme;
- neurovaskuläre, HNO- und Beckenerkrankungen (8,2%);
- Diabetesmanagement (7,4%): interne und externe Blutzuckerüberwachungssysteme und Insulinpumpen;
- neurologische Erkrankungen (5,5%): Neurostimulation und Produkte zur Verabreichung von Medikamenten auf Pump, Diagnoseinstrumente usw.
Der Nettoumsatz verteilt sich geographisch wie folgt: Irland (0,3%), die Vereinigten Staaten (50,9%) und Sonstige (48,8%).
Mitarbeiterzahl: 95 000
Umsatz nach Geschäftsbereich
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Cardiovascular
37,1
%
| 11 423 | 36,1 % | 11 573 | 37,1 % | +1,31 % |
Neuroscience
28,7
%
| 8 784 | 27,7 % | 8 959 | 28,7 % | +1,99 % |
Medical Surgical
27,0
%
| 9 141 | 28,8 % | 8 433 | 27,0 % | -7,75 % |
Diabetes
7,2
%
| 2 338 | 7,4 % | 2 262 | 7,2 % | -3,25 % |
Umsatz je Region
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
United States
52,4
%
| 16 134 | 50,9 % | 16 373 | 52,4 % | +1,48 % |
Non-United States Developed Markets
29,8
%
| 10 025 | 31,6 % | 9 310 | 29,8 % | -7,13 % |
Emerging Markets
17,4
%
| 5 426 | 17,1 % | 5 446 | 17,4 % | +0,37 % |
Ireland
0,3
%
| 101 | 0,3 % | 98 | 0,3 % | -2,97 % |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Geoffrey Martha
CEO | Chief Executive Officer | 54 | 26.01.15 |
Karen Parkhill
DFI | Director of Finance/CFO | 58 | 01.06.16 |
Gregory Smith
COO | Chief Operating Officer | 60 | 01.04.21 |
Laura Mauri
CTO | Chief Tech/Sci/R&D Officer | - | 01.09.18 |
Chief Tech/Sci/R&D Officer | 63 | 01.06.23 | |
Investor Relations Contact | - | 01.06.99 | |
Raman Venkatesh
PRN | Corporate Officer/Principal | - | 21.02. |
Robert White
PRN | Corporate Officer/Principal | 61 | 01.01.15 |
Yushao Gu
PRN | Corporate Officer/Principal | 55 | 01.01.15 |
Corporate Officer/Principal | 53 | 01.05.18 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Scott Donnelly
BRD | Director/Board Member | 62 | 01.01.13 |
Kendall Powell
BRD | Director/Board Member | 70 | 01.01.07 |
Randall Hogan
BRD | Director/Board Member | 68 | 01.01.15 |
Denise O'Leary
BRD | Director/Board Member | 66 | 01.01.00 |
Craig Arnold
BRD | Director/Board Member | 64 | 26.01.15 |
Kevin Lofton
BRD | Director/Board Member | 69 | 15.09.20 |
Lidia Fonseca
BRD | Director/Board Member | 55 | 27.06.22 |
Geoffrey Martha
CEO | Chief Executive Officer | 54 | 26.01.15 |
Elizabeth Nabel
BRD | Director/Board Member | 72 | 01.01.14 |
Gregory Lewis
BRD | Director/Board Member | 53 | 26.06.23 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 1 327 822 539 | 1 325 100 746 ( 99,80 %) | 0 | 99,80 % |
Unternehmensbesitz
Name | Aktien | % | Bewertung |
---|---|---|---|
5 868 916 | 16,42% | 37 795 819 $ |
Unternehmenskontakt
Konzerngesellschaften
Name | Kategorie und Branche |
---|---|
Medtronic, Inc.
Medtronic, Inc. Medical SpecialtiesHealth Technology Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN. |
Medical Specialties
|
Covidien Group SARL
Covidien Group SARL Medical SpecialtiesHealth Technology Part of Medtronic Plc, Covidien Group SARL is a Luxembourger company that manufactures medical devices, diagnostic imaging agents, and pharmaceuticals. The private company is based in Luxembourg, Luxembourg. |
Medical Specialties
|
Covidien LP
Covidien LP Medical SpecialtiesHealth Technology Covidien LP manufactures and distributes medical devices. Its products include disposable medical supplies, monitoring equipment, innovative wound closure products, advanced surgical devices, medical instruments and bulk analgesic pharmaceuticals. The company is headquartered in Mansfield, MA. |
Medical Specialties
|
Medtronic International Technology, Inc.
| |
Arterial Vascular Engineering Canada Co.
| |
Arterial Vascular Engineering UK Ltd.
Arterial Vascular Engineering UK Ltd. Financial ConglomeratesFinance Part of Medtronic Plc, Arterial Vascular Engineering UK Ltd. provides investment services. The private company is based in London, UK. Founded in 1995. |
Financial Conglomerates
|
Medtronic AB
| |
Medtronic Korea Co. Ltd.
Medtronic Korea Co. Ltd. Hospital/Nursing ManagementHealth Services Medtronic Korea Co., Ltd. engages in the manufacture and sale of medical products. It operates through the follow businesses: Cardiac and Vascular, Minimally Invasive Therapies, Restorative Therapies, and Diabettes. The company was founded on June 21. 2000 and is headquartered in Seoul, South Korea. |
Hospital/Nursing Management
|
Medtronic Bakken Research Center BV
Medtronic Bakken Research Center BV Medical SpecialtiesHealth Technology Part of Medtronic Plc, Medtronic Bakken Research Center BV is a Dutch company that specializes in providing innovative products, services, and solutions to help spine surgeons overcome their biggest challenges. The private company is based in Maastricht, Netherlands. The company also offers products for neurological procedures, surgery, neurostimulation, and drug infusion systems for chronic pain and severe spasticity. Founded in 1987, the company offers care management services that provide remote patient monitoring programs to improve patient health and deliver economic benefits to the healthcare system. |
Medical Specialties
|
Sektor
Umsatz nach Geschäftsbereich
Umsatz je Region
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
+5,79 % | 116 Mrd. | |
+3,26 % | 197 Mrd. | |
+1,48 % | 71,49 Mrd. | |
+11,77 % | 53,47 Mrd. | |
+18,31 % | 48,42 Mrd. | |
+6,33 % | 43,64 Mrd. | |
+12,38 % | 28,97 Mrd. | |
+9,76 % | 28,47 Mrd. | |
+10,35 % | 27,78 Mrd. | |
+18,09 % | 27,08 Mrd. |
- Börse
- Aktien
- Aktie Medtronic plc - Nyse
- Unternehmen Medtronic plc